Background: Bronchiolitis obliterans organizing pneumonia is a rare disease that mimics infectious pneumonia. Most patients respond well to corticosteroid therapy.
toms and signs of bronchiolitis obliterans organizing pneumonia mimic infectious pneumonia, but therapy for this condition is corticosteroids, not antibiotics. Bronchoalveolar lavage or open-lung biopsy might be required for definitive diagnosis. Most patients respond well to treatment, but a subset of patients, less than 10 percent of all patients, will die of this illness. We describe a case of ostensibly progressive disease that could have been complicated by superinfection. We want physicians to be wary of the combination of prolonged antibiotic use and high-dose corticosteroids.
Methods
We report a single case of bronchiolitis obliterans organizing pneumonia and findings from an English language literature search of MEDLINE using key words "bronchiolitis obliterans organizing . " pneumoma.
Illustrative Case A 55-year-old man complained to his family physician of a 3-week history of exhaustion, dysp-nea, fever and chills, and 15-to 20-pound weight loss. He was a long-term heavy smoker (40 to 80 pack years) and a frequent traveler. Recent travel was limited to metropolitan areas in the United States. His chest radiograph showed emphysematous changes and a possible early right lower lobe infiltrate. Clarithromycin was prescribed (500 mg twice a day for 10 days), but he had no clinical response and sought care again 1 week later. During this time he developed a small amount of hemoptysis. He was given an injection of ceftriaxone and prescribed cephalexin. A truncal rash appeared after cephalosporin administration, and he again returned. His antibiotic was changed to ofloxacin (400 mg twice a day). After only 1 day of ofloxacin therapy, he returned to his physician's office. A repeated chest radiograph showed a patchy alveolar right lower lobe infiltrate and small left lower lobe infiltrate. He was admitted to the hospital for further evaluation and treatment.
'When admitted to the hospital, the patient weighed 145 pounds, his temperature was 97.6°F, pulse 72 beats per minute, respirations 18/min, and blood pressure 132176 mmHg. He was cachectic and had decreased breath sounds and dullness at the right lung base. He also had pedal edema (2+) and pretibial edema (1+) bilaterally. Oxygen saturation on room air was 60 percent. His arterial blood gas readings on 6 L of oxygen per minute by nasal cannula were pH 7.41, p02 61 mmHg, pCO z 78 mmHg, oxygen saturation 93 percent, and bicarbonate 38.2 mEqIL.
On day 3 he developed rales on chest auscultation, which persisted throughout his hospitalization. Extensive laboratory studies showed pancytopenia, hypoalbuminemia, and hypocalcemia. He was given intravenous clindamycin (600 mg three times a day) and gentamicin (320 mg/d), but his fever persisted. Clarithromycin (500 mg twice a day) was added on day 3. His peripheral edema resolved, and subjectively he improved slightly after supplemental oxygen. Sputum and blood cultures were repeated many times and were negative. Findings from an echocardiogram to rule out right heart failure and endocarditis and a vascular Doppler study of the lower extremities to exclude deep venous thrombosis were noncontributory.
A Westergren erythrocyte sedimentation rate was 117 mmlh and an alpha I-antitrypsin level was 435 mg/dL (roughly two times the upper limit of normal). Rheumatoid factor and antinuclear antibody titers were negative; a Mycoplasma immunoglobulin G (IgG) level was positive at 0.35 mg/dL.
Bilateral infiltrates seen on chest radiographs persisted without improvement and developed an interstitial pattern.
A noninfectious cause was suspected. The differential diagnoses included bronchiolitis obliterans organizing pneumonia, vasculitis, and lymphoma. The result of a bone marrow biopsy to evaluate the pancytopenia and to assess for an infiltrative process was non diagnostic dysplasia.
At an open-lung biopsy there was boggy edematous parenchyma with bullous and panacinar emphysema. Special stains and cultures were negative for all organisms except methicillin-resistant Staphylococcus aureus (MRSA) in the broth. A Legionella titer (whether IgG or IgM was unknown) was less than 1:128 with a total antibody level of 5.4 mg/dL. Histologic sections showed a noninfectious organizing pneumonia with vasculitis limited to the affected area.
Postoperatively, the patient was given highdose intravenous methylprednisolone, but he had no clinical response. An antinuclear cytoplasmic antibody level was negative. The patient's clinical course deteriorated; he had persistent oxygen desaturation with exertion and progressive weakness, and he did not eat. Tube feedings were initiated. Impending respiratory failure led to intubation and mechanical ventilation. A Swan-Ganz catheter was placed. The patient developed multiple organ-system failure with rapid rises in renal 42 JABFP Jan.-Feb. 1998 Vol. 
Epidemiology
No sex predilection exists for bronchiolitis obliterans organizing pneumonia. 1-10 This disease is found in adults whose average age falls within the sixth decade oflife. l -ll Two to four cases are estimated to occur each year at large medical centers. ll ,12 One report of a projected cumulative prevalence was 12 per 100,000 admissions at a major teaching medical center. lO
Cause and Etiologic Associations
Although two thirds of cases are considered idiopathic, bronchiolitis obliterans organizing pneumonia has been associated with connective tissue disorders, organ transplants, toxic fume inhalation, and drug toxicity. ronchoalveolar lavage cell findings appear to change slowly, requiring months to years to revert to norma1. 6 Prednisone or prednisolone prescribed in dosages of 1 to 1.5 mglkg/d for 1 to 3 months is a standard practice. 1 ,4-7 Intravenous methylprednisolone may be given as initial therapy for 3 to 5 days at 1 to 3 gld in divided doses. 5 ,9 Early tapering of treatment frequently results in relapse. Some cases have required treatment for longer than 1 year. 1 ,4,lO In progressive, refractory cases, cytotoxic agents, such as cyclophosphamide and azathioprine, have been tried without success. 5 ,9 Two cases of resolution have been reported after treatment with erythromycin in one case and erythromycin and tetracycline in the other; however, the author of the report considered these resolutions to be spontaneous, as no infectious agent was identified in either case. 1 Outcome Generally, 60 to 70 percent of patients have complete resolution after corticosteroid treatment. l -12 Twenty to 30 percent improve with some residual deficits either on pulmonary function testing or in radiographic findings. to An estimated less than 10 percent of patients succumb to progressive disease. 1 . S ,7,8,lO In a 1995 review of 296 cases worldwide, 10 Alasaly et al report 65 percent, 27 percent, and 8 percent, respectively, for the above outcomes.
Discussion
The clinicopathologic syndrome now referred to as bronchiolitis obliterans organizing pneumonia might have been described as early as 1901.1 In 1985 Eplerl was the first to categorize the clinical and histologic findings into a single entity. Although the general theme is constant, variations have led to some difficulty in interpreting what should actually be considered bronchiolitis obliterans organizing pneumonia, particularly with regard to whether the histologic findings are associated with any kind of exposure or infection. The term cryptogenic organizing pneumonia is preferred by some authors but should be applied only if the disease is considered to be idiopathic. lO ,30,31,H-35 Authors disagree about whether bronchiolitis obliterans organizing pneumonia belongs in the spectrum of interstitial diseases. 9 ,32 Recent evidence indicates that interstitial scarring and honeycombing can occur with atypical, progressive disease.
9 Differential diagnoses include usual interstitial pneumonitis, chronic eosinophilic pneumonia, infectious pneumonitis, local organizing pneumonia, diffuse alveolar damage, hypersensitivity pneumonitis, Wegener's granulomatosis, and lymphoproliferative disorders. The diagnostic differ- If dyspnea is mild and the cause is considered idiopathic, the prognosis is good, with the p;ltient experiencing either spontaneous resolution or prompt response to corticosteroid treatment. Severe dyspnea and a more prolonged or rapidly progressive course are associated with a poor prognosis. Concomitant connective tissue disorder is also associated with a poor prognosis. Patchy infiltrates in multiple lobes seen on chest radiographs or CT scans are associated with good prognosis, whereas bilateral interstitial infiltrates are associated with poor prognosis. Findings of mixed cellularity on bronchoalveolar lavage are associated with good prognosis, whereas a lack of lymphocytosis on bronchoalveolar lavage portends a poor prognosis (fable 1 ).1,3,5,9,12
The patient described here had a clinical course similar to that of a group of patients who had rapidly progressive disease reported by Cohen et aI.9 Our patient's underlying emphysema and generally weakened state might have contributed to his poor response. The prolonged use of multiple antibiotics (outpatient and inpatient) could have contributed to the development of a multiresistant organism that was able to disseminate in the presence of high-dose corticosteroids. The MRSA in our patient might have been the multiresistant organism that first appeared in the broth and then caused overwhelming sepsis.
Conclusion
Bronchiolitis obliterans organizing pneumonia is a rare syndrome characterized by cough, dyspnea, weight loss, fever, and rales. Most patients respond well to corticosteroid therapy. A subset of patients with severe dyspnea, prolonged course, and bilateral interstitial infiltrates seen on chest radiograph tend to have poor prognosis. Lack of lymphocytosis on bronchoalveolar lavage is also an important finding in predicting poor response to therapy. Bronchiolitis obliterans organizing pneumonia should be considered when a presumptive diagnosis of community-acquired pneumonia does not respond to appropriate treatment.
If a patient has multiple patchy infiltrates, characteristic bronchoalveolar lavage patterns, and no response to antibiotics, it would be appropriate to consider proceeding to corticosteroid therapy without open-lung biopsy. A tissue sample is required for definitive diagnosis, however. The clinician must be wary of infection by a multiresistant organism as a consequence of multiple antibiotic therapy with concomitant use of corticosteroids, particularly when no initial infecting organism is identified.
